ClinicalTrials.Veeva

Menu

Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease (SenTra)

T

Tel Aviv Sourasky Medical Center

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Dementia

Treatments

Device: GPS modem and RFID

Study type

Interventional

Funder types

Other

Identifiers

NCT00743418
DIP-K.3.1.

Details and patient eligibility

About

The research is aimed at exploring the application of novel tracking technique for the study of spatial activity among dementia patients and its implication on their families. The study sample will be composed of three groups of volunteers, each including100 participants aged over 60 years. The first group will include MCI (Mild Cognitive Impairment) patients. The second group will include patients that suffer from mild dementia. The third group will include age matched healthy participants. The tracking equipment will be a GPS apparatus of 450 gms that will be carried by the participants for 24 hours along 2-4 weeks. The GPS data will be transferred via the cellular network to operator center at the Hebrew university at Jerusalem, and will be documented in assigned data files. This monitoring procedure will be held every year and along a period of five years. The impact of the patient behavior on the care giver will be studied by means of five interviews along the tracking period.

Enrollment

300 estimated patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with MCI, Alzheimer's disease, or mixed type dementia; OR

  • Healthy control subjects who meet the following criteria:

    • Mini Mental State (MMSE) of at least 21
    • Age 60 years or older
    • Patients with history of stroke which is not followed by cognitive decline may be included
    • Fluent language skills

Exclusion criteria

  • Other dementias (e.g. vascular, frontotemporal, metabolic etc);
  • Other major psychiatric disorders (e.g. major depression, schizophrenia);
  • Substance abuse;
  • MMSE 20 or less;
  • Severe motor disturbances;
  • Sensory deficits potentially affecting mobility; OR
  • Severe physical disorders (e.g. cancer, major operation)

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 3 patient groups

1
Other group
Description:
Healthy controls Mini Mental State evaluation score \>28/30
Treatment:
Device: GPS modem and RFID
2
Other group
Description:
Mild Cognitive Impairment: Mini Mental State Evaluation Score (MMSE)=26-28/30
Treatment:
Device: GPS modem and RFID
3
Other group
Description:
Mild Dementia: Mini Mental State Evaluation Score (MMSE)=21-25/30
Treatment:
Device: GPS modem and RFID

Trial contacts and locations

1

Loading...

Central trial contact

Jeremia Heinik, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems